Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Caronna, E
- Mas-de-les-Valls, R
- Gabriella, E
- Vázquez, MM
- Membrilla, J
- Vaghi, G
- Rodríguez-Montolio, J
- Fabra, NF
- Caballero, FS
- Sanchez, AJ
- Muñoz-Vendrell, A
- Oliveira, R
- Gárate, G
- Osorio, YG
- Ornello, R
- Sanahuja, J
- Cabral, G
- Blasco, IB
- Waliszewska-Prosól, M
- Pereira, L
- Layos-Romero, A
- Luzeiro, I
- Dorado, L
- Escudero, MRA
- May, A
- López-Bravo, A
- Martins, IP
- Sundal, C
- Irimia, P
- Ros, AL
- Gago-Veiga, AB
- Juanes, FV
- Ruscheweyh, R
- Sacco, S
- Cuadrado-Godia, E
- García-Azorín, D
- Pascual, J
- Gil-Gouveia, R
- Huerta-Villanueva, M
- Rodriguez-Vico, J
- Romero, JV
- Obach, V
- Santos-Lasaosa, S
- Ghadiri-Sani, M
- Tassorelli, C
- de Terán, JD
- Oria, CG
- Barbanti, P
- Pozo-Rosich, P
- Eureka Study Grp
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Caronna,E,Mas,R,Gabriella,E,Vázquez,MM,Castellanos,CN,Membrilla,J,Vaghi,G et al. Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?. 22nd International Headache Congress (IHC). 2025. Sao Paulo. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND:SAGE PUBLICATIONS LTD. 2025 p.p. 11-14.
Portal de investigación